![Josiah Craver](data:image/svg+xml,<svg xmlns="http://www.w3.org/2000/svg" width="16" height="16" fill="%231b1b1b" class="bi bi-person-fill" viewBox="0 0 16 16"><path d="M3 14s-1 0-1-1 1-4 6-4 6 3 6 4-1 1-1 1zm5-6a3 3 0 1 0 0-6 3 3 0 0 0 0 6"/></svg>)
Josiah Craver
Comptroller/Controller/Revisor på
FAETH THERAPEUTICS, INC.
Förmögenhet: - $ per 2026-07-31
Profil
Josiah Craver is Chief Accounting Officer & Senior VP-Finance at Faeth Therapeutics, Inc. starting in 2026.
Former positions include Senior Vice President & Controller at Kala Bio, Inc., and Vice President-Finance at Solid Biosciences, Inc. from 2020.
Education includes undergraduate and graduate degrees from Stonehill College, Inc.
Kända innehav i offentliga företag
| Företag | Datum | Antal aktier | Värdering | Värderingsdatum |
|---|---|---|---|---|
| 2026-07-21 | 0 ( -.--% ) | - $ | 2026-07-31 |
Aktiva positioner av Josiah Craver
| Företag | Position | Start |
|---|---|---|
| FAETH THERAPEUTICS, INC. | Comptroller/Controller/Revisor | 2024-09-17 |
Tidigare kända positioner av Josiah Craver
| Företag | Position | Slut |
|---|---|---|
| SOLID BIOSCIENCES INC. | Comptroller/Controller/Revisor | 2020-03-01 |
| KALA BIO, INC. | Comptroller/Controller/Revisor | - |
Josiah Cravers utbildningar
Erfarenheter
Innehade positioner
Aktiva
Inaktiva
Börsnoterade företag
Privata företag
Relationer
29
Första gradens relationer
4
Företag kopplade till första graden
Man
Kvinna
Styrelseledamöter
Chefer
Kopplade företag
| Privata företag | 4 |
|---|---|
Kala Bio, Inc.
 Kala Bio, Inc. Pharmaceuticals: MajorHealth Technology Operates as a clinical-stage biopharmaceutical company developing mesenchymal stem cell secretive (MSC-S) therapies | Health Technology |
Stonehill College, Inc.
 Stonehill College, Inc. Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
Solid Biosciences, Inc.
 Solid Biosciences, Inc. BiotechnologyHealth Technology Operates as a pharmaceutical company that develops treatments through gene therapy for patients with duchenne disease | Health Technology |
Sensei Biotherapeutics, Inc.
 Sensei Biotherapeutics, Inc. BiotechnologyHealth Technology Operates as clinical-stage biopharmaceutical company, which develops immunotherapies for cancers and infectious disease | Health Technology |
